Lisdexamfetamine dimesylate (Vyvanse) toxicosis in a dog
Journal of Veterinary Emergency and Critical Care · 2024-03 · 34 (2) · 193-198
DOI: 10.1111/vec.13370 ↗At a glance
Fallbericht in Journal of Veterinary Emergency and Critical Care, published online on 2024-02-27. Written by Danielle M Martindale and 4 co-authors. Institution: Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, Illinois, USA. Major MEDLINE topics: Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity. Cited 1 times so far (Crossref); 14 references.
Abstract (original language)
Objective To describe the presentation, management, and postmortem examination findings in a dog with confirmed lisdexamfetamine dimesylate (LDX) toxicosis. Case Summary A 3‐year‐old female neutered mixed breed dog initially presented with neurological signs suspected to be secondary to LDX toxicosis. The dog was treated as typical for amphetamine toxicoses but developed severe respiratory and cardiovascular signs throughout their hospitalization. The progression of the cardiopulmonary signs led to cardiopulmonary arrest, for which CPR was unsuccessful. Postmortem examination exhibited severe hemorrhage throughout multiple organ systems. Toxicology testing confirmed the presence of unaltered LDX and its metabolite, amphetamine. New or Unique Information Provided This is the first case report documenting a severe progression of clinical signs and postmortem examination findings in a case of confirmed LDX toxicosis in a dog. Although the patient did not survive treatment, postmortem examination and microscopic evaluation of tissues allowed visualization of the extent of systemic pathophysiology. With prompt treatment, the prognosis of amphetamine toxicosis in dogs is generally considered good; however, this case report demonstrates a severe case in which even prompt and appropriate treatment did not prevent mortality. This suggests a need to establish negative prognostic indicators for which to monitor in cases of amphetamine toxicosis. Finally, this report is also unique in the fact that the LDX toxicosis was confirmed using a toxicological analysis technique not previously described clinically in dogs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana, Illinois, USA.
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois, Urbana, Illinois, USA.
- Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, Michigan, USA.
ORCID profiles: Jenica L Haraschak
Cite
APA
Martindale, D. M., Haraschak, J. L., Thiel, A. J., Samuelson, J. P., & Buchweitz, J. P. (2024). Lisdexamfetamine dimesylate (Vyvanse) toxicosis in a dog. Journal of Veterinary Emergency and Critical Care, 34(2), 193-198. https://doi.org/10.1111/vec.13370
Vancouver
Martindale DM, Haraschak JL, Thiel AJ, Samuelson JP, Buchweitz JP. Lisdexamfetamine dimesylate (Vyvanse) toxicosis in a dog. Journal of Veterinary Emergency and Critical Care. 2024;34(2):193-198. doi:10.1111/vec.13370
BibTeX
@article{Martindale2024,
author = {Martindale, Danielle M and Haraschak, Jenica L and Thiel, Andrew J and Samuelson, Jonathan P and Buchweitz, John P},
title = {Lisdexamfetamine dimesylate (Vyvanse) toxicosis in a dog},
journal = {Journal of Veterinary Emergency and Critical Care},
year = {2024},
volume = {34},
number = {2},
pages = {193--198},
doi = {10.1111/vec.13370}
}
EUVIMED